Craig Horbinski
Research Interests
Explore related searches
Contact this professor
Get a free first email built on one of their papers, ready for you to edit and send yourself.
Articles (19)
Year:
2025
Year:
2025
Year:
2025
Year:
2025
Year:
2025
Year:
2024
Year:
2024
Year:
2023
Summary Treatment of IDH-mutated non-enhancing grade 2 and 3 diffuse gliomas with ivosidenib leads to reduction of tumor size when assessed via volumetric MRI. Isocitrate dehydrogenase inhibition has a therapeutic benefit in patients with these tumors. See related article by Kamson et al., p. 4863
Year:
2023
Year:
2023
Year:
2023
Year:
2023
Year:
2023
Year:
2022
Year:
2022
Year:
2022
Year:
2022
Year:
2022
Year:
2022
Collaborators (13)
Martin van den Bent
Erasmus University Rotterdam
Atique Ahmed
Professor
Northwestern University
Matthew McCord
Assistant Professor
University of Virginia School of Medicine
Igal Ifergan
Assistant Professor
University of Cincinnati
Daniele Procissi
Northwestern University
Chunming Cheng
Ohio State University
Matthias Preusser
Medical University
Anshika Goenka
Fred Hutch Cancer Center
Shiyuan Cheng
Professor
Northwestern University Feinberg School of Medicine
Roberta Goncalves Marangoni
Research Assistant Professor
University of Rochester School of Medicine and Dentistry
Song Xiao
Northwestern University
Matthew Tate
Assistant Professor
Northwestern University Feinberg School of Medicine
Louis Nabors
Professor
The University of Alabama
Make your next move.
Prepare your application
Review drafts before you send them.